June 2020

Scientific advice concerning the COVID-19 pandemic

The SARS-CoV-2 virus is a pathogen previously unknown to science and medicine. To date, there is still a dearth of information on the virus itself, the spread of the disease, and the causes of excess deaths.

Looking beyond the chain of infection, there is limited understanding of how the measures that have been taken to fight the pandemic are disrupting health systems, businesses, trade chains, and society more generally, as well as how all of these interconnect with each other. Regarding the future, the possibility exists that societies will have to live long-term with COVID-19. It will take time for scientific knowledge to be advanced to a level that will allow the disease to be kept under control. Nevertheless, evidence from science, which is often required at short notice, is crucial to help develop sound public policy. It raises the question of how scientific advice can be best given to European policy makers when knowledge is fast evolving, risks are large, and evidence is preliminary and limited. This question is particularly difficult because there are many uncertainties, outcomes and risks that need to be considered as well as at times limited scientific evidence, which means politicians have to face difficult trade-offs sometimes requiring controversial and unpopular decisions.

On this page

Delivered on
23 June 2020
Origin
Requested by the European Commission

Core advice

The European Group on Ethics gave advice in the form of an Opinion, including policy recommendations. More about how we develop our advice >

Supporting work

To support the Group in its work, the EGE secretariat provided an analysis of the policy landscape. More about our knowledge-gathering >

News and events

News  24 June 2020

Joint statement on scientific advice to European policy makers in the fight against the COVID-19 pandemic

Today the European Commission’s independent Group of Chief Scientific Advisors (GCSA), the European Group on Ethics in Science and New Technologies (EGE) and Peter Piot, special advisor to the President of the European Commission, Ursula von der Leyen, published a joint statement on scientific advice to European policy makers concerning the COVID-19 pandemic.